Australia is closely watching the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor therapy, representing a potential advance in obesity treatment . Early clinical trials have demonstrated https://giant-bikes750512.cosmicwiki.com/2727809/new_treatment_in_australia_a_new_hope_for_reducing_body_weight